238 related articles for article (PubMed ID: 33224889)
21. The analytical determination of isoprenoid intermediates from the mevalonate pathway.
Nürenberg G; Volmer DA
Anal Bioanal Chem; 2012 Jan; 402(2):671-85. PubMed ID: 21789486
[TBL] [Abstract][Full Text] [Related]
22. Control of RAS mRNA level by the mevalonate pathway.
Dimster-Denk D; Schafer WR; Rine J
Mol Biol Cell; 1995 Jan; 6(1):59-70. PubMed ID: 7749195
[TBL] [Abstract][Full Text] [Related]
23. Targeting Oncogenic Mutant p53 for Cancer Therapy.
Parrales A; Iwakuma T
Front Oncol; 2015; 5():288. PubMed ID: 26732534
[TBL] [Abstract][Full Text] [Related]
24. Statins, Mevalonate Pathway and its Intermediate Products in Placental Development and Preeclampsia.
Ermini L; Post M; Caniggia I
Curr Mol Pharmacol; 2017; 10(2):152-160. PubMed ID: 26758951
[TBL] [Abstract][Full Text] [Related]
25. Interconnection of Estrogen/Testosterone Metabolism and Mevalonate Pathway in Breast and Prostate Cancers.
Mokarram P; Alizadeh J; Razban V; Barazeh M; Solomon C; Kavousipour S
Curr Mol Pharmacol; 2017; 10(2):86-114. PubMed ID: 26758947
[TBL] [Abstract][Full Text] [Related]
26. Inhibition of mutant Kras and p53-driven pancreatic carcinogenesis by atorvastatin: Mainly via targeting of the farnesylated DNAJA1 in chaperoning mutant p53.
Xu D; Tong X; Sun L; Li H; Jones RD; Liao J; Yang GY
Mol Carcinog; 2019 Nov; 58(11):2052-2064. PubMed ID: 31397499
[TBL] [Abstract][Full Text] [Related]
27. Cholesterol and beyond - The role of the mevalonate pathway in cancer biology.
Göbel A; Rauner M; Hofbauer LC; Rachner TD
Biochim Biophys Acta Rev Cancer; 2020 Apr; 1873(2):188351. PubMed ID: 32007596
[TBL] [Abstract][Full Text] [Related]
28. Detection of Small GTPase Prenylation and GTP Binding Using Membrane Fractionation and GTPase-linked Immunosorbent Assay.
Alizadeh J; Shojaei S; da Silva Rosa S; Rezaei Moghadam A; Zeki AA; Hashemi M; Los MJ; Gordon JW; Ghavami S
J Vis Exp; 2018 Nov; (141):. PubMed ID: 30474639
[TBL] [Abstract][Full Text] [Related]
29. Mevalonate-suppressive dietary isoprenoids for bone health.
Mo H; Yeganehjoo H; Shah A; Mo WK; Soelaiman IN; Shen CL
J Nutr Biochem; 2012 Dec; 23(12):1543-51. PubMed ID: 22981371
[TBL] [Abstract][Full Text] [Related]
30. Statin-Induced Cancer Cell Death Can Be Mechanistically Uncoupled from Prenylation of RAS Family Proteins.
Yu R; Longo J; van Leeuwen JE; Mullen PJ; Ba-Alawi W; Haibe-Kains B; Penn LZ
Cancer Res; 2018 Mar; 78(5):1347-1357. PubMed ID: 29229608
[TBL] [Abstract][Full Text] [Related]
31. Kruppel-like factor 2 mediated anti-proliferative and anti-metastasis effects of simvastatin in p53 mutant colon cancer.
Lu L; Huang W; Hu W; Jiang L; Li Y; Wu X; Yuan D; Li M
Biochem Biophys Res Commun; 2019 Apr; 511(4):772-779. PubMed ID: 30833076
[TBL] [Abstract][Full Text] [Related]
32. Inhibition of prenyltransferase activity by statins in both liver and muscle cell lines is not causative of cytotoxicity.
Gee RH; Spinks JN; Malia JM; Johnston JD; Plant NJ; Plant KE
Toxicology; 2015 Mar; 329():40-8. PubMed ID: 25578243
[TBL] [Abstract][Full Text] [Related]
33. Ovarian tumour growth is characterized by mevalonate pathway gene signature in an orthotopic, syngeneic model of epithelial ovarian cancer.
Greenaway JB; Virtanen C; Osz K; Revay T; Hardy D; Shepherd T; DiMattia G; Petrik J
Oncotarget; 2016 Jul; 7(30):47343-47365. PubMed ID: 27329838
[TBL] [Abstract][Full Text] [Related]
34. Inhibition of the mevalonate pathway ameliorates anoxia-induced down-regulation of FKBP12.6 and intracellular calcium handling dysfunction in H9c2 cells.
Yang Y; Lu X; Rong X; Jiang W; Lai D; Ma Y; Zhou K; Fu G; Xu S
J Mol Cell Cardiol; 2015 Mar; 80():166-74. PubMed ID: 25636197
[TBL] [Abstract][Full Text] [Related]
35. Effects of mevalonate kinase interference on cell differentiation, apoptosis, prenylation and geranylgeranylation of human keratinocytes are attenuated by farnesyl pyrophosphate or geranylgeranyl pyrophosphate.
Li M; Min W; Wang J; Wang L; Li Y; Zhou N; Yang Z; Qian Q
Exp Ther Med; 2020 Apr; 19(4):2861-2870. PubMed ID: 32256770
[TBL] [Abstract][Full Text] [Related]
36. Inhibiting prenylation augments chemotherapy efficacy in renal cell carcinoma through dual inhibition on mitochondrial respiration and glycolysis.
Huang J; Yang X; Peng X; Huang W
Biochem Biophys Res Commun; 2017 Nov; 493(2):921-927. PubMed ID: 28943437
[TBL] [Abstract][Full Text] [Related]
37. Inhibition of the prenylation of K-Ras, but not H- or N-Ras, is highly resistant to CAAX peptidomimetics and requires both a farnesyltransferase and a geranylgeranyltransferase I inhibitor in human tumor cell lines.
Lerner EC; Zhang TT; Knowles DB; Qian Y; Hamilton AD; Sebti SM
Oncogene; 1997 Sep; 15(11):1283-8. PubMed ID: 9315095
[TBL] [Abstract][Full Text] [Related]
38. Disarming mutant p53 oncogenic function.
Girardini JE; Marotta C; Del Sal G
Pharmacol Res; 2014 Jan; 79():75-87. PubMed ID: 24246451
[TBL] [Abstract][Full Text] [Related]
39. Mutant p53 accumulation in human breast cancer is not an intrinsic property or dependent on structural or functional disruption but is regulated by exogenous stress and receptor status.
Bouchalova P; Nenutil R; Muller P; Hrstka R; Appleyard MV; Murray K; Jordan LB; Purdie CA; Quinlan P; Thompson AM; Vojtesek B; Coates PJ
J Pathol; 2014 Jul; 233(3):238-46. PubMed ID: 24687952
[TBL] [Abstract][Full Text] [Related]
40. Targeting the mevalonate pathway is a novel therapeutic approach to inhibit oncogenic FoxM1 transcription factor in human hepatocellular carcinoma.
Ogura S; Yoshida Y; Kurahashi T; Egawa M; Furuta K; Kiso S; Kamada Y; Hikita H; Eguchi H; Ogita H; Doki Y; Mori M; Tatsumi T; Takehara T
Oncotarget; 2018 Apr; 9(30):21022-21035. PubMed ID: 29765517
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
